Alafair Biosciences is a privately held, commercial-stage medical device company focused on the development of novel clinical products using its patented hydrogel technology. With a patent portfolio covering a broad range of clinical applications, Alafair is focused on building a robust product pipeline based on its proprietary technology. Its products are distributed through a dispersed network of independent distributors across the United States.
Location: United States, Texas, Austin
Employees: 11-50
Total raised: $2M
Founded date: 2011
Investors 2
| Date | Name | Website |
| - | TEXO Ventu... | texoventur... |
| 17.07.2021 | ATP Fund | atpfund.co... |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 10.08.2016 | Series A | $2M | - |
Mentions in press and media 9
| Date | Title | Description |
| 23.06.2021 | Eric Giza, MD, FACS Joins Alafair Biosciences Scientific & Clinical Advisory Board | |
| 24.09.2020 | Alafair Biosciences Receives 510(k) Clearance for VersaWrap® Nerve Protector | |
| 01.09.2016 | Ten Life Science Startups to Watch in Austin | |
| 10.08.2016 | Alafair Biosciences of Austin Raises $2 Million in Venture Capital | Alafair Biosciences, an Austin-based medical device startup, announced Wednesday it has received $2 million in venture funding. |
| 10.08.2016 | Medical Device Company Alafair Biosciences Completes $2.0M Series A Financing | Alafair Biosciences Inc., an Austin, Texas-based medical device company, completed a $2.0m Series A round of financing. The round was led by ATP Fund with participation from existing and new investors including the UT Horizon Fund. In conju... |
| 10.08.2016 | Alafair Biosciences Secures $2M Series A | AUSTIN, TX, Emerging medical device company, announced it has completed a $2.0 million Series A round of financing. >> Click here for more funding data on Alafair Biosciences >> To export Alafair Biosciences funding data to ... |
| 09.08.2016 | Alafair Biosciences Secures $2.0 Million Series A Financing Round | AUSTIN, Texas--(BUSINESS WIRE)--Alafair Biosciences Inc., an emerging medical device company, announced it has completed a $2.0 million Series A round of financing. ATP Fund led the investment round with participation from existing and new ... |
| 18.09.2013 | Adhesion barrier company raises $525K to prevent internal scarring after surgery | Alafair is developing a new material to keep tissues and organs separate while they heal. The product is a film created from naturally occurring sugar molecules that are well-established in wound healing and adhesion, the company says. A cl... |
| - | Adhesion barrier company raises $525K to prevent internal scarring after surgery | A Texas startup whose products could someday take on the likes of Genzyme, Ethicon and Baxter in the adhesion barrier market has collected a $525,000 equity investment from three investors, according to a new regulatory filing. Austin-based... |